Surfactant abnormalities in patients with respiratory failure after multiple trauma.
about
Surfactant alteration and replacement in acute respiratory distress syndromeEffect of hydrophobic surfactant proteins SP-B and SP-C on phospholipid monolayers. Protein structure studied using 2D IR and beta correlation analysis.Surfactant for pediatric acute lung injurySurfactant therapy for acute lung injury and acute respiratory distress syndrome.Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia.Recent advances in the treatment of ARDS.Close mimicry of lung surfactant protein B by "clicked" dimers of helical, cationic peptoids.LPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in mice.Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters surface tension properties.Effect of hydrophobic surfactant proteins SP-B and SP-C on binary phospholipid monolayers: II. Infrared external reflectance-absorption spectroscopy.Deacylated pulmonary surfactant protein SP-C transforms from alpha-helical to amyloid fibril structure via a pH-dependent mechanism: an infrared structural investigation.Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.Tumor necrosis factor-alpha-induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes is partially mediated by prostaglandinsBiophysical mimicry of lung surfactant protein B by random nylon-3 copolymersLung ventilation injures areas with discrete alveolar flooding, in a surface tension-dependent fashionInhaled diazeniumdiolates (NONOates) as selective pulmonary vasodilators.Visualization of phosphatidylcholine (16:0/16:0) in type II alveolar epithelial cells in the human lung using imaging mass spectrometry.Fetal and neonatal samples of a precursor surfactant protein B inversely related to gestational age.Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant proteinLysophosphatidylcholine Acyltransferase 1 (LPCAT1) Specifically Interacts with Phospholipid Transfer Protein StarD10 to Facilitate Surfactant Phospholipid Trafficking in Alveolar Type II CellsTime-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration.Exogenous surfactant therapy for ARDS.Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in micePharmacotherapy of acute lung injury and the acute respiratory distress syndrome.Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?Pharmacotherapy of acute lung injury and acute respiratory distress syndromeC/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.Pulmonary surfactant surface tension influences alveolar capillary shape and oxygenation.Surface tension in situ in flooded alveolus unaltered by albumin.Gas exchange in the respiratory distress syndromes.Ventilation-induced lung injury.Stat-3 is required for pulmonary homeostasis during hyperoxia.Surface tension influences cell shape and phagocytosis in alveolar macrophages.Host defence capacities of pulmonary surfactant: evidence for 'non-surfactant' functions of the surfactant system.Surfactant and the adult respiratory distress syndrome.The effect of diet-induced serum hypercholesterolemia on the surfactant system and the development of lung injury.Very low surfactant protein C contents in newborn Belgian White and Blue calves with respiratory distress syndrome.Sphingomyelin metabolites inhibit sphingomyelin synthase and CTP:phosphocholine cytidylyltransferase.Selected contribution: Lung hypoxia: antioxidant and antiapoptotic effects of liposomal alpha-tocopherol.Determinants of surfactant function in acute lung injury and early recovery.
P2860
Q24798768-6CB1F1D7-0044-4DDD-B511-584212BEF17CQ30331936-68B9B625-B6C7-4ED3-BD05-3C11F4D7BAA1Q30409008-B697938E-0029-476B-A6F4-70ABD33C0036Q30426177-26D075A7-3A34-4857-BAD3-5AA699267184Q32032889-0727583D-EFE3-4794-B3E5-F0BE62D664E8Q33566373-0B96BE29-A288-4FF2-96BF-86B19AD76A5AQ33813691-A462105B-0AF9-4C46-A814-C3C0F494DEE1Q33815707-A0DF49F1-249F-404A-A28F-F5AAC693FAC6Q34152702-1EFBB1DD-1B64-48B3-8F06-C90030A61497Q34180142-B85913C4-9196-42AE-BD79-C40B150A7CEBQ34183112-BB6D3864-7369-4EFD-8ABC-4CCC7F459A1BQ34214892-A09A47E6-8DB8-455D-9A93-CA50C691BCE8Q34235230-292548B6-747A-4090-993F-FC2C0D6EDD48Q34308721-C0424ED2-7210-4B27-881D-22E3D6D25AFAQ34602057-6F4136AB-7AEF-4877-963C-08AE09379E29Q34706962-6FA7F277-CAC3-44AE-B7F6-DABA57A7764DQ34732656-FA0D89BE-6C77-4FC6-82EB-67405FF8143AQ35013598-77E2E0EB-DF28-47F0-B380-93FBE45286B8Q35817606-533EDED1-1B91-4522-8665-76F961160063Q35883844-4F78B49D-C833-481E-A407-5C9F2965F469Q35945347-C6E3969D-FFDC-4F01-8804-A856AF2F0768Q36349649-58E20C7E-DFBA-4944-BFC7-5A7E75D354D9Q36431321-5EB84AE8-4AD3-4DA1-B6AE-4A53DE3DD0AFQ36467694-F78A3CF0-6751-469D-8BB2-B2848C0273E8Q36902581-866E1DE4-2ADB-4B70-8874-C8EE7E1FF965Q37085611-E0C23026-CC34-4393-8AF9-02271052BD7AQ37343865-DE7632E7-5A29-410B-935C-08AE491DD75AQ37353736-484CB1C6-D20B-43F6-9A84-A86A5C0EA68AQ37592497-73A4B0A2-C05D-4BB2-B607-8FA40650D175Q38110743-90DF88E9-4CA7-48A8-B3DB-386E008FC927Q38112053-8AAC6818-9CE3-4549-BB83-9D83C39E7547Q38346379-9F2AAA79-ECA2-43D3-B5B8-4EDBA5957E20Q40288649-A501194E-8934-4C88-BE75-12CB53EAFBB4Q40575234-C0D44F4E-93BD-4620-B57F-4B0B222F1FDAQ40869111-9315F616-D600-43B2-9B22-BA2161BBE164Q41129561-790DC0C2-1813-4D0D-8833-FE1BE57B1BA7Q42877403-38305A3F-6205-4C83-8E75-8D674699FBEFQ43638699-E3838713-9229-4BF1-B519-AE1B7440C95CQ44138667-30E8D55A-B112-4F15-965D-839E95ED02B3Q46529359-745B6FD3-6957-41FF-AF73-A29525283553
P2860
Surfactant abnormalities in patients with respiratory failure after multiple trauma.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Surfactant abnormalities in patients with respiratory failure after multiple trauma.
@en
Surfactant abnormalities in patients with respiratory failure after multiple trauma.
@nl
type
label
Surfactant abnormalities in patients with respiratory failure after multiple trauma.
@en
Surfactant abnormalities in patients with respiratory failure after multiple trauma.
@nl
prefLabel
Surfactant abnormalities in patients with respiratory failure after multiple trauma.
@en
Surfactant abnormalities in patients with respiratory failure after multiple trauma.
@nl
P2093
P2860
P356
P1476
Surfactant abnormalities in patients with respiratory failure after multiple trauma.
@en
P2093
Buchhorn R
Obertacke U
Schmit-Neuerburg KP
P2860
P304
P356
10.1164/AJRCCM/140.4.1033
P577
1989-10-01T00:00:00Z